Use of Adjuvant Immunotherapy and Early Overall Survival in Stage III Merkel Cell Carcinoma
Published: 26 June 2026| Version 1 | DOI: 10.17632/f8zzhfxmsx.1
Contributor:
Hue TranDescription
Use of Adjuvant Immunotherapy and Early Overall Survival in Stage III Merkel Cell Carcinoma
Files
Institutions
- Mayo ClinicMinnesota, Rochester
Categories
Epidemiology